Related references
Note: Only part of the references are listed.Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404)
Kristen Ganjoo et al.
LEUKEMIA & LYMPHOMA (2014)
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma
Daruka Mahadevan et al.
CANCER (2013)
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group
Yoshihiro Torimoto et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2013)
A multicenter phase II trial to determine the safety and efficacy of combination therapy with denileukin diftitox and cyclophosphamide, doxorubicin, vincristine and prednisone in untreated peripheral T-cell lymphoma: the CONCEPT study
Francine M. Foss et al.
LEUKEMIA & LYMPHOMA (2013)
SMILE for natural killer/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group
Yok-Lam Kwong et al.
BLOOD (2012)
Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study
Barbara Pro et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II Study
Takashi Ishida et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Up-Front Autologous Stem-Cell Transplantation in Peripheral T-Cell Lymphoma: NLG-T-01
Francesco d'Amore et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
Bertrand Coiffier et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Targeting Chemokine Receptor CCR4 in Adult T-Cell Leukemia-Lymphoma and Other T-Cell Lymphomas
Kensei Tobinai et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2012)
Comparison of four prognostic scores in peripheral T-cell lymphoma
G. Gutierrez-Garcia et al.
ANNALS OF ONCOLOGY (2011)
Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project
Dennis D. Weisenburger et al.
BLOOD (2011)
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
Owen A. O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Lenalidomide monotherapy for relapsed/refractory peripheral T-cell lymphoma not otherwise specified
Pier Luigi Zinzani et al.
LEUKEMIA & LYMPHOMA (2011)
Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group
Norbert Schmitz et al.
BLOOD (2010)
Clinical features and prognostic factors of patients with peripheral T cell lymphoma, unspecified
Yuna Lee et al.
ANNALS OF HEMATOLOGY (2009)
Analysis of prognostic factors in peripheral T-cell lymphoma: prognostic value of serum albumin and mediastinal lymphadenopathy
Dai Chihara et al.
LEUKEMIA & LYMPHOMA (2009)
Clinico-pathologic features and outcome of Japanese patients with peripheral T-cell lymphomas
Nozomi Niitsu et al.
HEMATOLOGICAL ONCOLOGY (2008)
International peripheral T-cell and natural killer/T-cell lymphoma study: Pathology findings and clinical outcomes
Julie M. Vose et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinicopathologic and prognostic significance of cytotoxic molecule expression in nodal peripheral T-cell lymphoma, unspecified
N Asano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma -: The MD Anderson Cancer Center experience
MP Escalón et al.
CANCER (2005)
Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years
WY Au et al.
ANNALS OF ONCOLOGY (2005)
Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study
A Gallamini et al.
BLOOD (2004)
Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification
KJ Savage et al.
ANNALS OF ONCOLOGY (2004)
Peripheral T-cell lymphomas: Clinical features and prognostic factors of 92 cases defined by the Revised European American lymphoma classification
ER Arrowsmith et al.
LEUKEMIA & LYMPHOMA (2003)
A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma
J Pellatt et al.
ANNALS OF HEMATOLOGY (2002)
T-cell non-Hodgkin's lymphoma in adults: Clinicopathological characteristics, response to treatment and prognostic factors
M Reiser et al.
LEUKEMIA & LYMPHOMA (2002)
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the non-Hodgkin's Lymphoma Classification Project
T Rudiger et al.
ANNALS OF ONCOLOGY (2002)
Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classification
K Kim et al.
EUROPEAN JOURNAL OF CANCER (2002)
Share Paper
